Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
L-PPDS Punctal Placement in Glaucoma/OH
NCT00821002Phase 2Completed
- Sponsor
- Mati Therapeutics
- Start
- Jan 2009
- Primary completion
- Nov 2009
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of latanoprost in open-angle glaucoma (OAG), ocular hypertension, sponsored by Mati Therapeutics. Started Jan 2009; status: completed.
02
Drugs
latanoprost
03
Conditions
open-angle glaucoma (OAG)ocular hypertension
Beyond the preview
Go deeper on NCT00821002.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00821002.